Dewislen
Chwilio
er enghraifft swydd, cwmni, sgiliau
er enghraifft dinas, sir neu god post

4 cytundeb, rhan amser, yn gyfan gwbl o bell, swydd yn Cambridge

wedi’u postio yn y 30 diwrnod diwethaf
Dangos hidlwyr

Hyderus o ran Anabledd

Gweithio o bell

Lleoliad

Dyddiad hysbysebu

Ystod cyflog

Categori

Math o gytundeb

Oriau

Canlyniadau 1-4 o 4
Dangos fesul tudalen a didoli drwy

Elderly Befriender

  • 08 June 2024
  • Home Instead - Sawston, Cambridge
  • £13.25 to £14.85 per hour
  • Yn gyfan gwbl o bell
  • Cytundeb
  • Rhan amser

Job description Elderly Befriender - Drivers needed. Care to Drink Tea and Eat Cake £14.85 per hour, guaranteed hours Availability to work Monday to Friday and alternate weekends (£14.85 earned wage including holiday pay) Home Instead Cambridge is expanding ...

Elderly Befriender

  • 08 June 2024
  • Home Instead - Cambourne, Cambridge
  • £13.25 to £14.85 per hour
  • Yn gyfan gwbl o bell
  • Cytundeb
  • Rhan amser

Job description Elderly Befriender - Drivers needed. Care to Drink Tea and Eat Cake £14.85 per hour, guaranteed hours Availability to work Monday to Friday and alternate weekends (£14.85 earned wage including holiday pay) Home Instead Cambridge is expanding ...

Elderly Befriender

  • 08 June 2024
  • Home Instead - Girton, Cambridge
  • £13.25 to £14.85 per hour
  • Yn gyfan gwbl o bell
  • Cytundeb
  • Rhan amser

Job description Elderly Befriender - Drivers needed. Care to Drink Tea and Eat Cake £14.85 per hour, guaranteed hours Availability to work Monday to Friday and alternate weekends (£14.85 earned wage including holiday pay) Home Instead Cambridge is expanding ...

Fractional CSO/Advisor - mRNA biotech

  • 03 June 2024
  • Hays Specialist Recruitment - Cambridge, Cambridgeshire, CB2 0AA
  • £2,000.0 to £2,400.0 per day
  • £200-300 per hour
  • Yn gyfan gwbl o bell
  • Cytundeb
  • Rhan amser

Your new company You will be joining a breakthrough VC backed biotech who have recently raised a multi-million pound Seed funding round.They are pioneering novel treatments in the field of cancer immunoprevention and are currently developing a lead mRNA ...

  • 1